Share
Tumor size and random growth hormone concentration at diagnosis are the best predictors for remission of acromegaly after transsphenoidal surgery (TSS), according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Eva C. Coopmans, MD, of Erasmus University Medical Center in Rotterdam, The Netherlands, point out that TSS...
Share
New pooled data from Phase 2 and Phase 3 clinical trials further reinforce that teprotumumab-trbw significantly improves proptosis (eye bulging) and diplopia (double vision) for thyroid eye disease (TED) in patients in different subgroups, with most maintaining a long-term response. The results were published recently in The Lancet Diabetes & Endocrinology. Teprotumumab-trbw is a fully human...
Share
Machine learning (ML), a type of artificial intelligence, could be used to predict how patients with acromegaly respond to first-generation somatostatin receptor ligands (fg-SRLs), according a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Mônica Gadelha, MD, PhD, of the Endocrine Unit and Neuroendocrinology Research Center at the Medical...
Share
Recently, Metro Health – University of Michigan Health, an affiliate of University of Michigan Health, announced that it reduced incidence of hypoglycemia by more than 54% and experienced a 40% decline in hyperglycemia since implementing personalized insulin dosing software. Glytec is marketing the software as the eGlycemic Management System® (eGMS). Extensive research links poor glycemic control...
Share
Three in four patients say telehealth quality of care is similar to in-person visits Two-thirds of patients with chronic endocrine health problems who need close monitoring say they would like to continue with telemedicine follow-up visits after the COVID-19 pandemic ends, according to a survey presented virtually at ENDO 2021. Three-quarters of providers also said...
Share
Data from a Phase 3 trial presented this week at ENDO2021 showed that octreotide capsules improved clinical symptoms and other patient-reported outcomes compared to long-acting injectable somatostatin receptor ligands (iSRLs) in patients with acromegaly. The data went on to show that 90% of patients receiving octreotide capsules elected to enroll in the open-label extension (OLE)...
Share
The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to AZP-3601, Amolyt Pharma’s clinical candidate for the treatment of hypoparathyroidism. “We believe the FDA’s granting of Orphan Drug Designation to AZP-3601 reflects the agency’s recognition that new and more effective treatment options are needed for this serious endocrine disorder,” says Endocrine...
Share
[Editor’s note: This post has been updated to clarify that the meta-analysis published in Diabetologia and the Phase IIb trial were separate studies.] Earlier this fall, Phase IIb topline results of the DIAGNODE-2 trial demonstrated a potential type 1 diabetes vaccine GAD-alum — an immunomodulating antigen-specific therapy – had a highly significant and clinically relevant...
If you are looking for a resource to ensure your endocrinology practice is up to date with legal and medical news, want to ensure you are meeting your patients’ needs to the best of your ability, and wish to be aware of recent advances in endocrinology, then Endocrine News has the right tools for you. Our Practice page is dedicated to providing information that is helpful and insightful for those running an endocrinology practice. Here you will find a collection of articles that provide current, relevant and vital information to help with your decisions as you run your practice.
Stay Current with Recent Advances in Endocrinology
As new technology hits the medical world and new discoveries about the endocrine system are made, you need the right information to continue to provide your patients with skilled medical care. Here you will find updated news and information about advances in the field, consolidated into one convenient location to help you save time while staying current. Rather than monitoring several news sites and digging for pertinent information, you can simply visit one page and have it all at your fingertips — saving you time as you run a busy practice.
See Clinical Endocrinology News That’s Relevant to Your Practice
On Endocrine News, you will also find the clinical news specific to the field of endocrinology that will help you make the best possible decisions for your clinic and your patients. From recent discoveries to research studies, you will have access to the most accurate and recent information available in the field. All of the reports, results and studies you need to see are here for you to search.
Improve Your Practice with Industry-Specific Tips and Tricks
In addition to the technical and medical industry research and reports you will find here, Endocrine News has the resources you need to keep your practice profitable and effective. From legal advice and tips to time management and patient interaction recommendations, you’ll find advice, insight and more that will help you run an efficient clinic that keeps your patients’ needs at the forefront of all you do.
